Susan M. Pond

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

Ronald T. Mitsuyasu, Thomas C. Merigan, Andrew Carr et al. · Nature Medicine · 2009 · 263 citations · Full text

Gene Therapy Trial, Medicine, Human Retrovirus +11

Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by Human Liver Carboxylesterase

Laurent P. Rivory, Mark R. Bowles, Jacques Robert et al. · Biochemical Pharmacology · 1996 · 230 citations

Biosynthesis, Human Liver Carboxylesterase, Biochemistry +6

Gastric emptying in acute overdose: a prospective randomised controlled trial

Susan M. Pond, David J Lewis‐Driver, Gail Williams et al. · The Medical Journal of Australia · 1995 · 190 citations

Altered methadone pharmacokinetics in methadone-maintained pregnant women.

Susan M. Pond, M J Kreek, T G Tong et al. · Journal of Pharmacology and Experimental Therapeutics · 1985 · 187 citations

Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients.

Laurent P. Rivory, Jean‐François Riou, Marie‐Christine Haaz et al. · PubMed · 1996 · 133 citations

Pharmaceutical Science, Pharmacotherapy, Major Plasma Metabolite +16